Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 55,000 shares at $15.76 ($867K) on 2025-01-21, disclosed to the SEC on 2025-01-22.
Scheduled sale ($867k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.76 | 53,375 | $841K | 97.0% |
| 2 | $16.19 | 1,625 | $26K | 3.0% |
| Total | $15.77 avg | 55,000 | $867K | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |